What is the main business of Artenamed?

The main business activity of Artenamed focuses on specialist medical practice activities.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on May 24, 2021.

Where is the headquarters located?

The headquarters is located at: ul. Karola Bohdanowicza 21, 02-127 Warszawa.

What is the share capital?

The share capital of the company is PLN 500,000 (approx. $135,062).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What revenue was generated?

The company reported a revenue of $36,377 in 2024, which is a decrease of 49.7% compared to 2023.

No, in 2024 the company was not profitable, reporting a net loss of $33,445. For comparison, in 2023 the loss was $30,803, meaning the company increased its loss by 3.1%.

Which cost dominates operating expenses?

The largest operating cost category falls under depreciation and amortization. This category amounted to $41,692 in 2024, representing 68% of all operating expenses.

Artenamedsp. z o.o.

Specialist medical practice activities

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2021-05-24

Share capital

500,000.00 PLN

Registered address

ul. Karola Bohdanowicza 21/28, 02-127 Warszawa, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 3 of 4 financial statements were filed late (the longest delay 188 days for 2022).

2025not filed
202401/09/2025
202311/04/2024
202219/01/2024
202130/09/2022

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue

This companyUSD 36.38kMedianUSD 443.18kAverageUSD 1.74m

Net profit

This companyUSD -33.44kMedianUSD 14.27kAverageUSD 128.63k

Operating costs

This companyUSD 61.66kMedianUSD 395.77kAverageUSD 1.56m

Assets

This companyUSD 144.35kMedianUSD 173.69kAverageUSD 1.02m

Industry

Authorized Representatives

Krystyna Frączyk Rams – Management Board Member

Manner of representation

In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Ownership

Owner	Shares	Share value	Stake
Krystyna Frączyk Ramsage 50	2,500	$67,531.06	50%
Barbara Grzymałaage 53	2,500	$67,531.06	50%

Beneficial owners

Person	Rights

Debt

No entries in the National Debtors Register (KRZ).

Public aid

Grant date	Purpose	Gross amount	Granting body
Sep 16, 2022	De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)	$573$573	Prezes Zakładu Ubezpieczeń Społecznych

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Competitors

Name	Revenue	Website
Nectar Polskasp. z o.o.	$528,123.00	klinikametoda.pl
Astimedsp. z o.o.	$498,540.18	astimed.pl
I. V. Clinicsp. z o.o.	$510,444.80	ivclinic.com.pl
MAAMsp. z o.o.	$455,593.52	urmed.pl
Saska Medsp. z o.o.	$241,826.45	saskamed.pl
Promindsp. z o.o.	$89,181.48	promindclinic.pl
Onkomedicasp. z o.o.	$69,344.55	onkomedica.pl
Biocells Medicalsp. z o.o.	$11,508.17	biocellsmedical.com
Bodyclinicsp. z o.o.	$3,758.46	bodyclinic.pl
Regenerumclinicsp. z o.o.	$1,427.86	regenerumclinic.pl

Change history

Date	Event
2023-08-04	Address change (Ul. Gen. Augusta Emila Fieldorfa "nila" 5a, 03-984, Warszawa → Ul. Karola Bohdanowicza 21/28, 02-127, Warszawa)
2022-12-02	Share capital increase (100,000.00 PLN → 500,000.00 PLN)
2021-05-24	Entered in the register

FAQ

Last updated: 2026-04-27